Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 859
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
for
Breast Neoplasm
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: Female
Age: 18 - 70+
Code: NCT06294574
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for
Tophaceous Gout
Location: Birmingham AL, Foley AL, Decatur GA, New Orleans LA,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089888
Phase3, Recruiting
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
for
Oncology, Myeloid Leukemia, Acute, Cancer
Location: Birmingham AL, Winston-Salem NC, Chapel Hill NC,
Sponsor: University of Rochester
Sex: All
Age: 60+
Code: NCT06697600
Recruiting
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
for
Alopecia Areata
Location: Birmingham AL, Louisville KY, Charlotte NC,
Sponsor: AnaptysBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05205070
Phase2, Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for
Heart Failure
Location: Birmingham AL, Nashville TN, St Louis MO, Houston TX,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 40 - 70+
Code: NCT06979362
Phase2, Recruiting
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
for
Pulmonary Sarcoidosis
Location: Birmingham AL, Charleston SC, Cincinnati OH, Chicago IL,
Sponsor: Xentria, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05890729
Phase1, Phase2, Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
for
Acute Promyelocytic Leukemia (APL),
Location: Birmingham AL, Nashville TN, Augusta GA, Lexington KY,
Sponsor: Quetzal Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07504458
Phase3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Birmingham AL, Memphis TN, Atlanta GA, Nashville TN,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07304089
Phase2, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Birmingham AL, New Orleans LA, Tallahassee FL,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Birmingham AL, Mobile AL, Chattanooga TN, Pensacola FL,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
Regulation of Inflammatory Genes in Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05507125
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Birmingham AL, Nashville TN, Carbondale IL, O'Fallon IL,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT07211178
Recruiting
Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)
for
Stickler Syndrome Type 1, Stickler Syndrome Type 2
Location: Birmingham AL, Nashville TN, Royal Oak MI, Rochester MN,
Sponsor: Helen Keller Eye Research Foundation
Sex: All
Age: 0+
Code: NCT07146516
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Birmingham AL, Columbus MS, New Albany MS, Grenada MS,